Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don’t work for everyone. In tho

The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some patients are finding a way around both of these concerns by experimenting with microdosing the drugs.

Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South with higher rates of obesity.

Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.

In this edition of Newsmaker, FOX 10's John Hook first talks with Dr. Swathi Varanasi-Diaz about the impact of weight loss drugs like Wegovy or Ozempic. In the second segment, John chats with Baywatch star and author,

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.